South America Biosimilars Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South America BiosimilaSrs Market – by Disease Indication

1.3.2 South America Biosimilars Market – by Drug class

1.3.3 South America Biosimilars Market – by Route of Administration

1.3.4 South America Biosimilars Market – by End User

1.3.5 South America Biosimilars Market – by Country

2. South America Biosimilars Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South America Biosimilars Market – Market Landscape

4.1 Overview

4.2 South America PEST Analysis

4.3 Expert’s Opinion

5. South America Biosimilars Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Cost Effectiveness of Biosimilar Drugs

5.1.3 Rising Approvals of Biosimilars

5.2 Market Restraints

5.2.1 High-Cost Involvement and Complexities in Biosimilar Product Manufacturing

5.3 Market Opportunities

5.3.1 Patent Expiry of Blockbuster Biologics

5.4 Future Trend

5.4.1 Collaborations for Biosimilars and Clinical Trials

5.5 Impact analysis

6. Biosimilars Market – South America Analysis

6.1 South America Biosimilars Market Revenue Forecast and Analysis

7. South America Biosimilars Market – Revenue and Forecast to 2028 – by Disease Indication

7.1 Overview

7.2 South America Biosimilars Market Revenue Share, by disease indication 2021 & 2028 (%)

7.3 Cancer

7.3.1 Overview

7.3.2 Cancer: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Diabetes

7.4.1 Overview

7.4.2 Diabetes: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Autoimmune Diseases

7.5.1 Overview

7.5.2 Autoimmune Diseases: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3 Psoriasis:

7.5.3.1 Overview

7.5.3.2 Psoriasis: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4 Arthritis:

7.5.4.1 Overview

7.5.4.2 Arthritis: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5 Others:

7.5.5.1 Overview

7.5.5.2 Others: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Others Disease Indications

7.6.1 Overview

7.6.2 Others Disease Indications: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

8. South America Biosimilars Market Analysis and Forecast to 2028 – by Drug Class

8.1 Overview

8.2 South America Biosimilars Market, by Drug class 2021 & 2028 (%)

8.3 Granulocyte colony-stimulating factors

8.3.1 Overview

8.3.2 Granulocyte colony-stimulating factors Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Insulin

8.4.1 Overview

8.4.2 Insulin Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

8.5 TNF Blockers and Monoclonal Antibodies

8.5.1 Overview

8.5.2 TNF Blockers and Monoclonal Antibodies Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Biosimilars Market Analysis and Forecasts to 2028 – by Route of Administration

9.1 Overview

9.2 South America Biosimilars Market, by Application 2021 & 2028 (%)

9.3 Intravenous

9.3.1 Overview

9.3.2 Intravenous: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Subcutaneous

9.4.1 Overview

9.4.2 Subcutaneous: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Biosimilars Market – Revenue and Forecast to 2028 – by End User

10.1 Overview

10.2 South America Biosimilars Market Revenue Share, by End User 2021 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Specialty Clinics

10.4.1 Overview

10.4.2 Specialty Clinics: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Homecare

10.5.1 Overview

10.5.2 Homecare: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Other

10.6.1 Overview

10.6.2 Other: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11. South America Biosimilars Market – Revenue and Forecast to 2028 – Country Analysis

11.1 Overview

11.1.1 South America: Biosimilars Market, by Country, 2021 & 2028 (%)

11.1.1.1 Brazil: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1 Overview

11.1.1.1.2 Brazil: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3 Brazil: Biosimilars Market, by Disease Indication, 2019–2028 (US$ Million)

11.1.1.1.3.1 Brazil: Biosimilars Market, by Autoimmune Diseases, 2019–2028 (US$ Million)

11.1.1.1.4 Brazil: Biosimilars Market, by Drug Class, 2019–2028 (US$ Million)

11.1.1.1.5 Brazil: Biosimilars Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.1.6 Brazil: Biosimilars Market, by End User, 2019–2028 (US$ Million)

11.1.1.2 Argentina: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1 Overview

11.1.1.2.2 Argentina: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3 Argentina: Biosimilars Market, by Disease Indication, 2019–2028 (US$ Million)

11.1.1.2.3.1 Argentina: Biosimilars Market, by Autoimmune Diseases, 2019–2028 (US$ Million)

11.1.1.2.4 Argentina: Biosimilars Market, by Drug Class, 2019–2028 (US$ Million)

11.1.1.2.5 Argentina: Biosimilars Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.2.6 Argentina: Biosimilars Market, by End User, 2019–2028 (US$ Million)

11.1.1.3 Rest of South America: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1 Overview

11.1.1.3.2 Rest of South America: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3 Rest of South America: Biosimilars Market, by Disease Indication, 2019–2028 (US$ Million)

11.1.1.3.3.1 Rest of South America: Biosimilars Market, by Autoimmune Diseases, 2019–2028 (US$ Million)

11.1.1.3.4 Rest of South America: Biosimilars Market, by Drug Class, 2019–2028 (US$ Million)

11.1.1.3.5 Rest of South America: Biosimilars Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.3.6 Rest of South America: Biosimilars Market, by End User, 2019–2028 (US$ Million)

12. Biosimilars Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Biosimilars Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Amgen Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Sanofi SA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Biocon Ltd

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Eli Lilly and Co

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Sandoz AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Teva Pharmaceutical Industries Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Pfizer Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Dr. Reddy's Laboratories Ltd

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Comparison Between Different Drug Developments

Table 2. Brazil Biosimilars Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3. Brazil Biosimilars Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (US$ Million)

Table 4. Brazil Biosimilars Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 5. Brazil Biosimilars Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 6. Brazil Biosimilars Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Argentina Biosimilars Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 8. Argentina Biosimilars Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (US$ Million)

Table 9. Argentina Biosimilars Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 10. Argentina Biosimilars Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 11. Argentina Biosimilars Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. Rest of South America Biosimilars Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of South America Biosimilars Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of South America Biosimilars Market, by Drug Class – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of South America Biosimilars Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of South America Biosimilars Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Recent Inorganic Growth Strategies in the Biosimilars Market

Table 18. Recent Organic Growth Strategies in the Biosimilars Market

Table 19. Glossary of Terms

LIST OF FIGURES

Figure 1. South America Biosimilars Market Segmentation

Figure 2. South America Biosimilars Market, by Country

Figure 3. South America Biosimilars Market Overview

Figure 4. Cancer Segment Held Largest Share of Type Segment in South America Biosimilars Market

Figure 5. Argentina is Expected to Show Remarkable Growth During Forecast Period

Figure 6. South America: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. South America Biosimilars Market Impact Analysis of Drivers and Restraints

Figure 9. South America Biosimilars Market – Revenue Forecast and Analysis – 2020–2028

Figure 10. South America Biosimilars Market Revenue Share, by disease indication 2021 & 2028 (%)

Figure 11. Cancer: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Diabetes: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Autoimmune Diseases: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Psoriasis: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Arthritis: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Others Disease Indications: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. South America Biosimilars Market, by Drug class 2021 & 2028 (%)

Figure 19. Granulocyte colony-stimulating factors Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Insulin Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. TNF Blockers and Monoclonal Antibodies Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others Drug class: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. South America Biosimilars Market, by Application 2021 & 2028 (%)

Figure 24. Intravenous: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Subcutaneous: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. South America Biosimilars Market Revenue Share, by End User 2021 & 2028 (%)

Figure 28. Hospitals: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Specialty Clinics: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Homecare: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Other: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. South America: Biosimilars Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33. South America: Biosimilars Market, by Country, 2021 & 2028 (%)

Figure 34. Brazil: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Argentina: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Rest of South America: Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Growth Strategies in the Biosimilars Market